Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis

Ophthalmology and Therapy - United Kingdom
doi 10.1007/s40123-019-0171-0
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Giant-Cell Arteritis of the Legs

BMJ
1955English

Investigation and Management of Giant Cell Arteritis

Prescriber
Pharmacology
2020English

Design of the Tocilizumab in Giant Cell Arteritis Trial

International Journal of Rheumatology
RheumatologyImmunology
2013English

Myopericarditis and Giant Cell Arteritis in the Elderly

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

Giant Cell Arteritis.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1991English

The Treatment of Giant Cell Arteritis in Different Clinical Settings

Frontiers in Immunology
AllergyImmunology
2019English

Role of Oral Cyclophosphamide in the Treatment of Giant Cell Arteritis

Rheumatology
RheumatologyPharmacology
2012English

Giant Cell Arteritis: Is the Clinical Spectrum of the Disease Changing?

BMC Geriatrics
GerontologyGeriatrics
2019English

Internuclear Ophthalmoplegia in Giant Cell Arteritis.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy